APPROACHES TO ANTIVIRAL CHEMOTHERAPY

[1] BENNETT HPJ, 1986, INT J PEPT PROT RES, V27, P306

[2] BENNETT LL, 1988, BIOCHEM PHARMACOL, V37, P1233

[3] BENNETT LL, 1985, MOL PHARMACOL, V27, P666

[4] EVIDENCE THAT THE CARBOCYCLIC ANALOG OF ADENOSINE HAS DIFFERENT MECHANISMS OF CYTOTOXICITY TO CELLS WITH ADENOSINE KINASE-ACTIVITY AND TO CELLS LACKING THIS ENZYME [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (22) : 4106 - 4109

[5] BENNETT LL, 1966, MOL PHARMACOL, V2, P432

[6] BENNETT LL, 1968, MOL PHARMACOL, V4, P208

[7] STUDIES ON BIOCHEMICAL BASIS FOR ANTIVIRAL ACTIVITIES OF SOME NUCLEOSIDE ANALOGS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 255 (AUG8) : 342 - 358

[8] BERNAERTS R, 1984, ARCH INT PHYSIOL BIO, V92, pB74

[9] BODEY GP, 1968, CANCER CHEMOTH REP, V52, P315

[10] BORCHARDT RT, 1984, J BIOL CHEM, V259, P4353

[1] BENNETT HPJ, 1986, INT J PEPT PROT RES, V27, P306

[2] BENNETT LL, 1988, BIOCHEM PHARMACOL, V37, P1233

[3] BENNETT LL, 1985, MOL PHARMACOL, V27, P666

[4] EVIDENCE THAT THE CARBOCYCLIC ANALOG OF ADENOSINE HAS DIFFERENT MECHANISMS OF CYTOTOXICITY TO CELLS WITH ADENOSINE KINASE-ACTIVITY AND TO CELLS LACKING THIS ENZYME [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (22) : 4106 - 4109

[5] BENNETT LL, 1966, MOL PHARMACOL, V2, P432

[6] BENNETT LL, 1968, MOL PHARMACOL, V4, P208

[7] STUDIES ON BIOCHEMICAL BASIS FOR ANTIVIRAL ACTIVITIES OF SOME NUCLEOSIDE ANALOGS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 255 (AUG8) : 342 - 358

[8] BERNAERTS R, 1984, ARCH INT PHYSIOL BIO, V92, pB74

[9] BODEY GP, 1968, CANCER CHEMOTH REP, V52, P315

[10] BORCHARDT RT, 1984, J BIOL CHEM, V259, P4353